Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoto Sassa

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
World Journal of Urology|August 20, 2018
Objective impacts of tadalafil on storage and voiding function in male patients with benign prostatic hyperplasia: 1-year outcomes from a prospective urodynamic studyYoshihisa Matsukawa, Shun Takai, Tsuyoshi Majima, et al.
Urology|November 29, 2008
Direct visualization of renal hemodynamics affected by carbon dioxide-induced pneumoperitoneumNaoto Sassa, Ryohei Hattori, Tokunori Yamamoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 3, 2021
Development of an artificial intelligence diagnostic system for lower urinary tract dysfunction in menYoshihisa Matsukawa, Yoshitaka Kameya, Tomoichi Takahashi, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|August 14, 2008
[Case report of malignant sertoli cell tumor]Naoto Sassa, Yasushi Yoshino, Yoshihisa Matsukawa, et al.
Neurourology and Urodynamics|February 20, 2019
Comparison in the efficacy of fesoterodine or mirabegron add-on therapy to silodosin for patients with benign prostatic hyperplasia complicated by overactive bladder: A randomized, prospective trial using urodynamic studiesYoshihisa Matsukawa, Shun Takai, Tsuyoshi Majima, et al.
Pathology International|March 2, 2011
The post-operative pathological prognostic parameters of clear cell renal cell carcinoma in pT1a casesToshinori Nishikimi, Toyonori Tsuzuki, Takashi Fujita, et al.
Neurourology and Urodynamics|April 11, 2018
De novo overactive bladder after robot-assisted laparoscopic radical prostatectomyYoshihisa Matsukawa, Yashushi Yoshino, Shohei Ishida, et al.
American Journal of Clinical Pathology|September 19, 2013
Growth pattern, an important pathologic prognostic parameter for clear cell renal cell carcinomaAkitoshi Fukatsu, Toyonori Tsuzuki, Naoto Sassa, et al.
Histopathology|June 27, 2012
Is pT3 urothelial carcinoma of the renal pelvis a homogeneous disease entity? Proposal for a new subcategory of the pT3 classificationNaoto Sassa, Toyonori Tsuzuki, Akitoshi Fukatsu, et al.
American Journal of Clinical Pathology|March 18, 2015
Relationship of pathologic factors to efficacy of sorafenib treatment in patients with metastatic clear cell renal cell carcinomaHidemori Araki, Toyonori Tsuzuki, Tohru Kimura, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
World Journal of Urology|August 20, 2018
Objective impacts of tadalafil on storage and voiding function in male patients with benign prostatic hyperplasia: 1-year outcomes from a prospective urodynamic studyYoshihisa Matsukawa, Shun Takai, Tsuyoshi Majima, et al.
Urology|November 29, 2008
Direct visualization of renal hemodynamics affected by carbon dioxide-induced pneumoperitoneumNaoto Sassa, Ryohei Hattori, Tokunori Yamamoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 3, 2021
Development of an artificial intelligence diagnostic system for lower urinary tract dysfunction in menYoshihisa Matsukawa, Yoshitaka Kameya, Tomoichi Takahashi, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|August 14, 2008
[Case report of malignant sertoli cell tumor]Naoto Sassa, Yasushi Yoshino, Yoshihisa Matsukawa, et al.
Neurourology and Urodynamics|February 20, 2019
Comparison in the efficacy of fesoterodine or mirabegron add-on therapy to silodosin for patients with benign prostatic hyperplasia complicated by overactive bladder: A randomized, prospective trial using urodynamic studiesYoshihisa Matsukawa, Shun Takai, Tsuyoshi Majima, et al.
Pathology International|March 2, 2011
The post-operative pathological prognostic parameters of clear cell renal cell carcinoma in pT1a casesToshinori Nishikimi, Toyonori Tsuzuki, Takashi Fujita, et al.
Neurourology and Urodynamics|April 11, 2018
De novo overactive bladder after robot-assisted laparoscopic radical prostatectomyYoshihisa Matsukawa, Yashushi Yoshino, Shohei Ishida, et al.
American Journal of Clinical Pathology|September 19, 2013
Growth pattern, an important pathologic prognostic parameter for clear cell renal cell carcinomaAkitoshi Fukatsu, Toyonori Tsuzuki, Naoto Sassa, et al.
Histopathology|June 27, 2012
Is pT3 urothelial carcinoma of the renal pelvis a homogeneous disease entity? Proposal for a new subcategory of the pT3 classificationNaoto Sassa, Toyonori Tsuzuki, Akitoshi Fukatsu, et al.
American Journal of Clinical Pathology|March 18, 2015
Relationship of pathologic factors to efficacy of sorafenib treatment in patients with metastatic clear cell renal cell carcinomaHidemori Araki, Toyonori Tsuzuki, Tohru Kimura, et al.
Pageof 9